Study of TTX-MC138 in Subjects With Advanced Solid Tumors
NCT06260774
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
DRUG:
TTX-MC138
Sponsor
TransCode Therapeutics